APA (7th ed.) Citation

Wang, W., & Luo, Y. (2025). Targeting METTL16 attenuates mesangial cell viability and fibrosis in a high-glucose state by suppressing m6A modification and the expression of RAP1B. BMC Molecular & Cell Biology, 26(1), 1. https://doi.org/10.1186/s12860-025-00559-3

Chicago Style (17th ed.) Citation

Wang, Weixu, and Yanhong Luo. "Targeting METTL16 Attenuates Mesangial Cell Viability and Fibrosis in a High-glucose State by Suppressing M6A Modification and the Expression of RAP1B." BMC Molecular & Cell Biology 26, no. 1 (2025): 1. https://doi.org/10.1186/s12860-025-00559-3.

MLA (9th ed.) Citation

Wang, Weixu, and Yanhong Luo. "Targeting METTL16 Attenuates Mesangial Cell Viability and Fibrosis in a High-glucose State by Suppressing M6A Modification and the Expression of RAP1B." BMC Molecular & Cell Biology, vol. 26, no. 1, 2025, p. 1, https://doi.org/10.1186/s12860-025-00559-3.